FMR1 and fragile X syndrome: In the human, FMR1 gene deletions, promoter variants, missense, and nonsense mutations also result in an FXS phenotype [58,59,60,61] and formed the basis of a recent knock-in mouse that offers a new preclinical model for testing FXS drug candidates [62].